Monitoring CML patients responding to treatment with tyrosine kinase inhibitors-review and recommendations for 'harmonizing' current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results
収録刊行物
-
- Blood
-
Blood 108 128-137, 2006